Edanz can support your needs for strategic planning and scientific messaging through:
Executing on a publication plan, or an individual project, we develop high-quality manuscripts and congress materials:
Edanz Pharma provides high-quality strategic planning and evidence generation services. Edanz was founded in Japan in 1995, and joined M3 Group (Tokyo Stock Exchange First Section -securities code 2413) in 2019.
We have a team of international experts with deep academic and industry experience.
*Since April 2021, the Edanz’s medical communications business is known as “Edanz Pharma”.
Edanz strictly adheres to international guidelines regarding medical writing best practice, including GPP 2022, ISMPP, EMWA, ICMJE guidelines.